Kimberly-Clark to Acquire Kenvue in $48.7 Billion Deal
Kimberly-Clark (KMB) announces acquisition of Kenvue (KVUE) for $48.7 billion, creating a global health and wellness powerhouse with 10 billion-dollar brands serving consumers worldwide.
NOTRELOAD AI
Alvotech's Biosimilar Drug Faces FDA Setback Due to Manufacturing Issues
Alvotech receives FDA complete response letter for AVT05 biosimilar to Simponi, citing manufacturing facility deficiencies. Company revises 2025 revenue outlook downward.
Wall Street's Latest Stock Moves: Four Companies Catch Analyst Attention
B. Riley downgrades Rigetti Computing while UBS upgrades Cisco to Buy. Stifel initiates coverage on Intuitive Machines and Piper Sandler upgrades Roku. Here's what analysts are saying about RGTI, CSCO, LUNR, and ROKU.
Berkshire Hathaway Posts 34% Profit Jump, Cash Hits Record $381.7 Billion
Berkshire Hathaway's Q3 operating profits surge 34% to $13.5B driven by insurance gains. Cash reserves reach record $381.7B as Buffett continues selling stocks and halts buybacks.
Pfizer Sues Metsera and Novo Nordisk Over Breach of Merger Agreement
Pfizer files lawsuit against Metsera, its board, and Novo Nordisk for breaching a merger agreement, claiming illegal interference and regulatory risks in Novo Nordisk’s proposal.
Ironwood Rises as AbbVie’s Linzess Sales Beat Expectations
Ironwood shares climb after AbbVie reports strong Q3 Linzess sales of $315M, surpassing estimates and boosting investor confidence.